← All Genprex, INC filings

Genprex, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
GNPX
Genprex, INC
SCHEDULE: Ayrton Capital Discloses 2.69% Stake in Genprex
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri have filed a Schedule 13G reporting a 2.69% beneficial ownership stake in Genprex, Inc. through warrant holdings.
NASDAQ
GNPX
Genprex, INC
SCHEDULE: Ayrton Capital, Alto Fund Disclose 9.72% Stake in Genprex
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri have disclosed a 9.72% beneficial ownership stake in Genprex, Inc. through warrants.
NASDAQ
GNPX
Genprex, INC
SCHEDULE: Intracoastal Capital Discloses 4.99% Stake in Genprex
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 4.99% beneficial ownership stake in Genprex, Inc. common stock as of November 3, 2025.
NASDAQ
GNPX
Genprex, INC
SCHEDULE 13G: Swedish Insurer Forsakringsaktiebolaget Avanza Pension Discloses Minor Stake in Genprex Inc.
Forsakringsaktiebolaget Avanza Pension has filed a Schedule 13G, reporting beneficial ownership of 0.0230% of Genprex Inc.'s common stock as of December 31, 2024.